The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines

Linda W. Moore, Laura D. Byham-Gray, J. Scott Parrott, Diane Rigassio-Radler, Sreedhar Mandayam, Stephen L. Jones, William E. Mitch, A. Osama Gaber

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

The actual dietary protein intake of adults without and with different stages of chronic kidney disease is not known. To evaluate this we performed cross-sectional analyses of 16,872 adults (20 years of age and older) participating in the National Health and Nutrition Examination Survey 2001-2008 who completed a dietary interview by stage of kidney disease. Dietary protein intake was assessed from 24-h recall systematically collected using the Automated Multiple Pass Method. Complex survey analyses were used to derive population estimates of dietary protein intake at each stage of chronic kidney disease. Using dietary protein intake of adults without chronic kidney disease as the comparator, and after adjusting for age, the mean dietary protein intake was 1.30 g/kg ideal body weight/day (g/kgIBW/d) and was not different from stage 1 or stage 2 (1.28 and 1.25 g/kgIBW/d, respectively), but was significantly different in stage 3 and stage 4 (1.22 and 1.13 g/kgIBW/d, respectively). These mean values appear to be above the Institute of Medicine requirements for healthy adults and the NKF-KDOQI guidelines for stages 3 and 4 chronic kidney disease. Thus, the mean dietary protein intake is higher than current guidelines, even after adjusting for age.

Original languageEnglish (US)
Pages (from-to)724-732
Number of pages9
JournalKidney International
Volume83
Issue number4
DOIs
StatePublished - Apr 2013
Externally publishedYes

Keywords

  • chronic
  • chronic kidney disease
  • cross-sectional survey
  • diet records
  • dietary protein
  • renal insufficiency

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines'. Together they form a unique fingerprint.

Cite this